动脉粥样硬化中氟代脱氧葡萄糖摄取的决定因素。 - Suppr

Suppr

超能文献

Determinants of FDG uptake in atherosclerosis.

作者信息

Buettner Christoph, Rudd James H F, Fayad Zahi A

机构信息

Department of Medicine, Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, New York, NY, USA.

出版信息

JACC Cardiovasc Imaging. 2011 Dec;4(12):1302-4. doi: 10.1016/j.jcmg.2011.09.011.

DOI:10.1016/j.jcmg.2011.09.011

PMID:22172787

Abstract

摘要

相似文献

Determinants of FDG uptake in atherosclerosis.

JACC Cardiovasc Imaging. 2011 Dec;4(12):1302-4. doi: 10.1016/j.jcmg.2011.09.011.

Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.

JACC Cardiovasc Imaging. 2011 Dec;4(12):1294-301. doi: 10.1016/j.jcmg.2011.07.009.

Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.

J Nucl Cardiol. 2012 Dec;19(6):1211-25. doi: 10.1007/s12350-012-9631-9.

Role of FDG PET/CT in investigating the mechanisms underlying atherosclerotic plaque formation and evolution.

Rev Esp Med Nucl Imagen Mol. 2013 Jul-Aug;32(4):246-52. doi: 10.1016/j.remn.2013.04.001. Epub 2013 May 30.

Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.

Circ Res. 2015 Oct 23;117(10):835-45. doi: 10.1161/CIRCRESAHA.115.307024. Epub 2015 Sep 22.

Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.

Chin Med J (Engl). 2011 Mar;124(6):911-7.

Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.

Int J Cardiovasc Imaging. 2016 Jan;32(1):49-59. doi: 10.1007/s10554-015-0660-8. Epub 2015 Apr 22.

Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.

JACC Cardiovasc Imaging. 2011 Oct;4(10):1110-8. doi: 10.1016/j.jcmg.2011.08.007.

Identification of inflamed atherosclerotic lesions in vivo using PET-CT.

Inflammation. 2014 Apr;37(2):426-34. doi: 10.1007/s10753-013-9755-3.

Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.

JACC Cardiovasc Imaging. 2013 Nov;6(11):1172-82. doi: 10.1016/j.jcmg.2013.09.004.

引用本文的文献

Autoradiographical assessment of inflammation-targeting radioligands for atherosclerosis imaging: potential for plaque phenotype identification.

EJNMMI Res. 2021 Mar 17;11(1):27. doi: 10.1186/s13550-021-00772-z.

Imaging inflammation in atherosclerotic plaques, targeting SST with [In]In-DOTA-JR11.

J Nucl Cardiol. 2021 Dec;28(6):2506-2513. doi: 10.1007/s12350-020-02046-y. Epub 2020 Feb 5.

Imaging of atherosclerosis, targeting LFA-1 on inflammatory cells with In-DANBIRT.

J Nucl Cardiol. 2019 Oct;26(5):1697-1704. doi: 10.1007/s12350-018-1244-5. Epub 2018 Mar 13.

Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.

Cardiovasc Diabetol. 2016 Feb 6;15:26. doi: 10.1186/s12933-016-0340-6.

Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques.

Mol Imaging Biol. 2016 Feb;18(1):99-108. doi: 10.1007/s11307-015-0873-1.

(18)F-FDG PET and vascular inflammation: time to refine the paradigm?

J Nucl Cardiol. 2015 Apr;22(2):319-24. doi: 10.1007/s12350-014-9917-1.

In vivo and in vitro evidence that ⁹⁹mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery.

Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1710-9. doi: 10.1007/s00259-014-2764-0. Epub 2014 Apr 16.

PET imaging of chemokine receptors in vascular injury-accelerated atherosclerosis.

J Nucl Med. 2013 Jul;54(7):1135-41. doi: 10.2967/jnumed.112.114777. Epub 2013 May 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Determinants of FDG uptake in atherosclerosis.

作者信息

Buettner Christoph, Rudd James H F, Fayad Zahi A

机构信息

Department of Medicine, Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, New York, NY, USA.

出版信息

JACC Cardiovasc Imaging. 2011 Dec;4(12):1302-4. doi: 10.1016/j.jcmg.2011.09.011.

DOI:10.1016/j.jcmg.2011.09.011

PMID:22172787

Abstract

摘要

相似文献

Determinants of FDG uptake in atherosclerosis.

JACC Cardiovasc Imaging. 2011 Dec;4(12):1302-4. doi: 10.1016/j.jcmg.2011.09.011.

Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.

JACC Cardiovasc Imaging. 2011 Dec;4(12):1294-301. doi: 10.1016/j.jcmg.2011.07.009.

Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.

J Nucl Cardiol. 2012 Dec;19(6):1211-25. doi: 10.1007/s12350-012-9631-9.

Role of FDG PET/CT in investigating the mechanisms underlying atherosclerotic plaque formation and evolution.

Rev Esp Med Nucl Imagen Mol. 2013 Jul-Aug;32(4):246-52. doi: 10.1016/j.remn.2013.04.001. Epub 2013 May 30.

Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.

Circ Res. 2015 Oct 23;117(10):835-45. doi: 10.1161/CIRCRESAHA.115.307024. Epub 2015 Sep 22.

Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.

Chin Med J (Engl). 2011 Mar;124(6):911-7.

Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.

Int J Cardiovasc Imaging. 2016 Jan;32(1):49-59. doi: 10.1007/s10554-015-0660-8. Epub 2015 Apr 22.

JACC Cardiovasc Imaging. 2011 Oct;4(10):1110-8. doi: 10.1016/j.jcmg.2011.08.007.

Identification of inflamed atherosclerotic lesions in vivo using PET-CT.

Inflammation. 2014 Apr;37(2):426-34. doi: 10.1007/s10753-013-9755-3.

Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.

JACC Cardiovasc Imaging. 2013 Nov;6(11):1172-82. doi: 10.1016/j.jcmg.2013.09.004.

引用本文的文献

Autoradiographical assessment of inflammation-targeting radioligands for atherosclerosis imaging: potential for plaque phenotype identification.

EJNMMI Res. 2021 Mar 17;11(1):27. doi: 10.1186/s13550-021-00772-z.

Imaging inflammation in atherosclerotic plaques, targeting SST with [In]In-DOTA-JR11.

J Nucl Cardiol. 2021 Dec;28(6):2506-2513. doi: 10.1007/s12350-020-02046-y. Epub 2020 Feb 5.

Imaging of atherosclerosis, targeting LFA-1 on inflammatory cells with In-DANBIRT.

J Nucl Cardiol. 2019 Oct;26(5):1697-1704. doi: 10.1007/s12350-018-1244-5. Epub 2018 Mar 13.

Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.

Cardiovasc Diabetol. 2016 Feb 6;15:26. doi: 10.1186/s12933-016-0340-6.

Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques.

Mol Imaging Biol. 2016 Feb;18(1):99-108. doi: 10.1007/s11307-015-0873-1.

(18)F-FDG PET and vascular inflammation: time to refine the paradigm?

J Nucl Cardiol. 2015 Apr;22(2):319-24. doi: 10.1007/s12350-014-9917-1.

In vivo and in vitro evidence that ⁹⁹mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery.

Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1710-9. doi: 10.1007/s00259-014-2764-0. Epub 2014 Apr 16.

PET imaging of chemokine receptors in vascular injury-accelerated atherosclerosis.

J Nucl Med. 2013 Jul;54(7):1135-41. doi: 10.2967/jnumed.112.114777. Epub 2013 May 8.